303 related articles for article (PubMed ID: 33791297)
1. piRNA-823 Is Involved in Cancer Stem Cell Regulation Through Altering DNA Methylation in Association With Luminal Breast Cancer.
Ding X; Li Y; Lü J; Zhao Q; Guo Y; Lu Z; Ma W; Liu P; Pestell RG; Liang C; Yu Z
Front Cell Dev Biol; 2021; 9():641052. PubMed ID: 33791297
[TBL] [Abstract][Full Text] [Related]
2. IL11 signaling mediates piR-2158 suppression of cell stemness and angiogenesis in breast cancer.
Zhao Q; Qian L; Guo Y; Lü J; Li D; Xie H; Wang Q; Ma W; Liu P; Liu Y; Wang T; Wu X; Han J; Yu Z
Theranostics; 2023; 13(7):2337-2349. PubMed ID: 37153732
[TBL] [Abstract][Full Text] [Related]
3. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B.
Su JF; Zhao F; Gao ZW; Hou YJ; Li YY; Duan LJ; Lun SM; Yang HJ; Li JK; Dai NT; Shen FF; Zhou FY
Pathol Res Pract; 2020 Apr; 216(4):152848. PubMed ID: 32051106
[TBL] [Abstract][Full Text] [Related]
4. Piwi-Interacting RNAs: A New Class of Regulator in Human Breast Cancer.
Qian L; Xie H; Zhang L; Zhao Q; Lü J; Yu Z
Front Oncol; 2021; 11():695077. PubMed ID: 34295823
[TBL] [Abstract][Full Text] [Related]
5. PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome.
Fu A; Jacobs DI; Hoffman AE; Zheng T; Zhu Y
Carcinogenesis; 2015 Oct; 36(10):1094-102. PubMed ID: 26210741
[TBL] [Abstract][Full Text] [Related]
6. Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation.
Liu T; Wang J; Sun L; Li M; He X; Jiang J; Zhou Q
Cell Cycle; 2021 Aug; 20(16):1603-1616. PubMed ID: 34313525
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of RASSF1C piRNA target genes in lung cancer cells.
Reeves ME; Firek M; Jliedi A; Amaar YG
Oncotarget; 2017 May; 8(21):34268-34282. PubMed ID: 28423657
[TBL] [Abstract][Full Text] [Related]
8. Dual Function of CCAT2 in Regulating Luminal Subtype of Breast Cancer Depending on the Subcellular Distribution.
Xie H; Guo Y; Xu Z; Wang Q; Wang T; Gu Y; Li D; Liu Y; Ma W; Liu P; Zhao Q; Lü J; Liu J; Yu Z
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672487
[TBL] [Abstract][Full Text] [Related]
9. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
10. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
11. PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5.
Xie J; Xing S; Shen BY; Chen HT; Sun B; Wang ZT; Wang JW; Lu XX
Hum Cell; 2021 Mar; 34(2):550-563. PubMed ID: 33389678
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.
Xu Z; Liu C; Zhao Q; Lü J; Ding X; Luo A; He J; Wang G; Li Y; Cai Z; Wang Z; Liu J; Liu S; Li W; Yu Z
Pharmacol Res; 2020 Feb; 152():104628. PubMed ID: 31904506
[TBL] [Abstract][Full Text] [Related]
13. Effects of Novel ncRNA Molecules, p15-piRNAs, on the Methylation of DNA and Histone H3 of the CDKN2B Promoter Region in U937 Cells.
Wu D; Fu H; Zhou H; Su J; Zhang F; Shen J
J Cell Biochem; 2015 Dec; 116(12):2744-54. PubMed ID: 26205624
[TBL] [Abstract][Full Text] [Related]
14. PIWI-interacting RNAs are aberrantly expressed and may serve as novel biomarkers for diagnosis of lung adenocarcinoma.
Li J; Wang N; Zhang F; Jin S; Dong Y; Dong X; Chen Y; Kong X; Tong Y; Mi Q; Zhao Y; Zhang Y
Thorac Cancer; 2021 Sep; 12(18):2468-2477. PubMed ID: 34346164
[TBL] [Abstract][Full Text] [Related]
15. Multiplex bioimaging of piRNA molecular pathway-regulated theragnostic effects in a single breast cancer cell using a piRNA molecular beacon.
Lee YJ; Moon SU; Park MG; Jung WY; Park YK; Song SK; Ryu JG; Lee YS; Heo HJ; Gu HN; Cho SJ; Ali BA; Al-Khedhairy AA; Lee I; Kim S
Biomaterials; 2016 Sep; 101():143-55. PubMed ID: 27289065
[TBL] [Abstract][Full Text] [Related]
16. piR-39980 promotes cell proliferation, migration and invasion, and inhibits apoptosis via repression of SERPINB1 in human osteosarcoma.
Das B; Jain N; Mallick B
Biol Cell; 2020 Mar; 112(3):73-91. PubMed ID: 31879982
[TBL] [Abstract][Full Text] [Related]
17. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer.
Weng W; Liu N; Toiyama Y; Kusunoki M; Nagasaka T; Fujiwara T; Wei Q; Qin H; Lin H; Ma Y; Goel A
Mol Cancer; 2018 Jan; 17(1):16. PubMed ID: 29382334
[TBL] [Abstract][Full Text] [Related]
18. miR-29a-KLF4 signaling inhibits breast tumor initiation by regulating cancer stem cells.
Zhao Q; Shang Y; Lü J; Liu Y; Wang T; Li D; Li J; Lu Y; Wang Z; Yu Z
Int Immunopharmacol; 2024 Mar; 130():111797. PubMed ID: 38442582
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
20. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells.
Cheng J; Guo JM; Xiao BX; Miao Y; Jiang Z; Zhou H; Li QN
Clin Chim Acta; 2011 Aug; 412(17-18):1621-5. PubMed ID: 21616063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
